GEP20197029B - Antimicrobial composition and the use of thereof - Google Patents

Antimicrobial composition and the use of thereof

Info

Publication number
GEP20197029B
GEP20197029B GEAP2018014773A GEP20197029B GE P20197029 B GEP20197029 B GE P20197029B GE AP2018014773 A GEAP2018014773 A GE AP2018014773A GE P20197029 B GEP20197029 B GE P20197029B
Authority
GE
Georgia
Prior art keywords
dsm
strains sensitive
bacterio
antimicrobial composition
sensitive
Prior art date
Application number
Inventor
Biochimpharm Jsc
Original Assignee
Biochimpharm Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochimpharm Jsc filed Critical Biochimpharm Jsc
Priority to GEAP2018014773 priority Critical patent/GEP20197029B/en
Priority to PCT/GE2018/000003 priority patent/WO2019211635A1/en
Priority to EA202190207A priority patent/EA202190207A1/en
Priority to UAA202100843A priority patent/UA127292C2/en
Publication of GEP20197029B publication Critical patent/GEP20197029B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Antimicrobial composition contains bacterio¬phage strains sensitive to Staphylococcus aureus: DSM 32631, DSM 32629, DSM 32630, bacterio¬pha¬ge strains sensitive to Streptococcus pyogenes: DSM 32634, DSM 32635, bacteriophage strains sensitive to Escherichia coli: DSM 32612, DSM 32611, DSM 32610, bacteriophage strains sensitive to Proteus vulgaris: DSM 32613, DSM 32614, DSM 32615, bacteriophage strains sensitive to Pseudomonas aeruginosa: DSM 32616, DSM 32618, DSM 32617 and optionally pharmaceuti¬cally acceptable excipient. At that, all said bacteriophages are deposited in the German Collection of Microorganisms and Cell Cultures (DSMZ). The composition is used at the treatment and/or as prevention of purulent-inflammatory in people, animals and birds, as well.
GEAP2018014773 2018-05-02 2018-05-02 Antimicrobial composition and the use of thereof GEP20197029B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GEAP2018014773 GEP20197029B (en) 2018-05-02 2018-05-02 Antimicrobial composition and the use of thereof
PCT/GE2018/000003 WO2019211635A1 (en) 2018-05-02 2018-07-12 Antimicrobial composition and the use of thereof
EA202190207A EA202190207A1 (en) 2018-05-02 2018-07-12 ANTIMICROBIAL COMPOSITION AND ITS APPLICATION
UAA202100843A UA127292C2 (en) 2018-05-02 2018-07-12 Antimicrobial composition and the use of thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP2018014773 GEP20197029B (en) 2018-05-02 2018-05-02 Antimicrobial composition and the use of thereof

Publications (1)

Publication Number Publication Date
GEP20197029B true GEP20197029B (en) 2019-10-25

Family

ID=63207780

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP2018014773 GEP20197029B (en) 2018-05-02 2018-05-02 Antimicrobial composition and the use of thereof

Country Status (4)

Country Link
EA (1) EA202190207A1 (en)
GE (1) GEP20197029B (en)
UA (1) UA127292C2 (en)
WO (1) WO2019211635A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195159B (en) * 2020-09-29 2022-10-11 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） Bacteriophage and application thereof
CN112195160B (en) * 2020-09-29 2024-04-05 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） Phage and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009075884A1 (en) * 2007-12-12 2009-06-18 Intralytix, Inc. Novel e. coli bacteriophages and uses thereof
RU2412243C1 (en) * 2009-06-16 2011-02-20 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Strain of salmonella typhimurium bacteriophage s-394, possessing lytic activity
KR101261873B1 (en) * 2011-08-23 2013-05-14 대한민국 (식품의약품안전처장) Bacteriophage having bacteriocidal effect on Salmonella spp., the cause of sitotoxism
US8685696B2 (en) * 2012-06-13 2014-04-01 Intralytix, Inc. Salmonella bacteriophage and uses thereof
EP2781220A1 (en) * 2013-03-18 2014-09-24 PTC Phage Technology Center GmbH Bacteriophages against Salmonella and their use

Also Published As

Publication number Publication date
WO2019211635A1 (en) 2019-11-07
WO2019211635A8 (en) 2020-09-17
UA127292C2 (en) 2023-07-12
EA202190207A1 (en) 2021-10-06

Similar Documents

Publication Publication Date Title
MX2022006525A (en) Lysin polypeptides active against gram-negative bacteria.
WO2018106135A3 (en) Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof
EP4332217A3 (en) Antibacterial phage, phage peptides and methods of use thereof
WO2018208985A3 (en) Antibacterial compounds
BR112014023321A2 (en) Compositions comprising antibacterial phages and their uses
WO2018208987A3 (en) Antibacterial compounds
SG10201811361XA (en) Treatment of polybacterials infections
MX2021003084A (en) Antibacterial compounds.
GEP20197029B (en) Antimicrobial composition and the use of thereof
Gunjan et al. A comparative study of the effect of different topical agents on burn wound infections
Abbas Comparative antibacterial and antibiofilm activities of manuka honey and Egyptian clover honey
GEP20197030B (en) Antimicrobial composition against gastrointestinal infections and the use of thereof
Jang et al. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis
BR112022007926A2 (en) COCKTAIL COMPOSITIONS INCLUDING RESPIRATORY ANTIBACTERIAL PHAGES AND METHODS OF USE THEREOF
AU2012335397A8 (en) Novel bacteriophages
WO2010125196A3 (en) Bacteriophages specific to pak and cha strains of pseudomonas aeruginosa and their applications
Pahomov et al. Analysis of microflora in modern outpatient clinic
Deepika et al. Antimicrobial activity of Syzygium zeylanicum (L.) DC. and Syzygium Hemisphericum (Walp.) alston
Anyanwu Assessment of the in vitro antibacterial activity of honey on some common human pathogens
Motevasel et al. Antibacterial effect of Zataria multiflora Extract on MRSA
Talebi et al. Evaluation of the effect of smoke of Anbar Nasara (Donkey dung) extract on staphilococcus aureus and bacilus subtilis
Omonike et al. PP-010 Effect of three Nigerian medicinal plants on methicillin resistant Staphylococcus aureus (MRSA)
Ebrahimi et al. ANTIBACTERIAL EFFECT OF RHEUM RIBES ON ESCHERICHIA COLI
Hou et al. Biological characteristics and lytic activity of a virulent Staphylococcus aureus phage.
MD4722B1 (en) Antibacterial agent against Staphylococcus aureus bacteria